{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:40:57Z","timestamp":1772800857135,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,23]],"date-time":"2002-01-23T00:00:00Z","timestamp":1011744000000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:p>Objective.\u2014Assessment of best available evidence for tolerability of sumatriptan after inadvertent exposure during pregnancy.<\/jats:p>\n                  <jats:p>Background.\u2014Migraine's demography suggests that inadvertent exposure to acute therapies is likely during the earliest undiagnosed stages of pregnancy. The tolerability of such therapies under these conditions is not amenable to clinical trial for ethical reasons. In the United States, sumatriptan is currently labeled pregnancy category C (ie, not recommended for use during pregnancy unless the potential benefit justifies the potential risk to the fetus).<\/jats:p>\n                  <jats:p>Methods.\u2014Three types of adverse events were studied: spontaneous abortion, fetal abnormality, and obstetric complications. Traditional evidence\u2010based criteria were used to assess a search\u2010protocol product of four clinical studies and two case reports.<\/jats:p>\n                  <jats:p>Results.\u2014The single positive finding (\u201cpreterm delivery\u201d without low birth weight) was in the smallest study; this study was retrospective and the finding was externally inconsistent with the other three larger studies, all of which were prospective. No study followed children for more than 4 years, which is the period needed to identify the maximum number of congenital anomalies. Rigorous teratological technique was generally not employed. Post hoc power calculations were used to provide parameters of the hazard detectable by these studies in aggregate.<\/jats:p>\n                  <jats:p>Conclusions.\u2014Pregnancy categories B and C both seem feasible for sumatriptan. Within the limits of the examined studies, there is no evidence for any specific effect of sumatriptan on pregnancy outcome. Patients inadvertently exposed to sumatriptan during an early stage of pregnancy should be reassured by these data.<\/jats:p>","DOI":"10.1046\/j.1526-4610.2002.02007.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T06:49:38Z","timestamp":1027666178000},"page":"8-15","source":"Crossref","is-referenced-by-count":39,"title":["Evidence\u2010Based Assessment of Pregnancy Outcome After Sumatriptan Exposure"],"prefix":"10.1111","volume":"42","author":[{"given":"Anthony W.","family":"Fox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina D.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip O.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merle L.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egilius L.H.","family":"Spierings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,23]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3806436.x"},{"key":"e_1_2_7_3_2","first-page":"769","article-title":"Treatment of menstruation\u2010associated migraine headache with subcutaneous sumatriptan.","volume":"82","author":"Solbach MP","year":"1993","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.10.1517"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1991.hed3106372.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.18.2.197"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1993.hed3310533.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199819050-00005"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(93)90193-G"},{"issue":"3","key":"e_1_2_7_10_2","first-page":"S34","article-title":"5\u2010Hydroxytryptamine receptor subtypes and the pharmacology of migraine.","volume":"43","author":"Peroutka SJ","year":"1993","journal-title":"Neurology"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/12.2.361"},{"key":"e_1_2_7_12_2","first-page":"91","volume-title":"Evidence\u2010Based Medicine","author":"Sackett DL","year":"1999"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.2.581"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004040050252"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(00)70506-0"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00003.x"},{"key":"e_1_2_7_17_2","volume-title":"Sumatriptan and naratriptan pregnancy registries","author":"Glaxo\u2010Wellcome Inc","year":"2001"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(94)00150-O"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050894"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.040008677.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2000.00156.x"},{"key":"e_1_2_7_22_2","first-page":"117","volume-title":"Pharmaceutical Medicine","author":"Gore SM","year":"1985"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420510511"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.2527\/1992.7051615x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4320(98)00107-9"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0890-6238(93)90250-B"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/014107680009300913"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351402"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7271.1259"},{"key":"e_1_2_7_30_2","unstructured":"McRoryDC MatcharDB RosenbergJH SilbersteinSD. Evidence\u2010based guidelines for migraine headache. 2nd ed.1999. Available at:http:\/\/www. neurology.org. Accessed January 4 2001."},{"key":"e_1_2_7_31_2","unstructured":"MatcharDB YoungWB RosenbergJA et al. Evidence\u2010based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. Available at:http:\/\/www.aan.com. Accessed January 4 2001."},{"key":"e_1_2_7_32_2","unstructured":"RamadanNM SilbersteinSD FreitagFG GilbertTT FrishbergBM. Evidence\u2010based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Available at:http:\/\/www.neurology.org. Accessed January 4 2001."},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2000.00158.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.111006206.x"},{"key":"e_1_2_7_35_2","first-page":"332","article-title":"Evidence\u2010based assessment of pregnancy outcome after sumatriptan exposure [abstract].","volume":"20","author":"Fox AW","year":"2000","journal-title":"Cephalalgia"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-4610.2002.02007.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2002.02007.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:05:57Z","timestamp":1762088757000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-4610.2002.02007.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1046\/j.1526-4610.2002.02007.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-4610.2002.02007.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}